Novartis Capital $3 billion notes issue

17/2/2017
Investment grade bond/note issue

$ 3 billion

Completed

17/2/2017


Overview:

  • Novartis Capital has made a $3 billion notes issue.
  • The offering consisted of $1 billion 1.80% notes due 2020, $1 billion 2.40% notes due 2022 and $1 billion 3.10% notes due 2027.
  • Novartis Capital is the finance subsidiary of pharmaceutical company Novartis.
  • Underwriters included Citigroup Global Markets, JPMorgan Securities, Merrill Lynch Pierce Fenner & Smith and Credit Suisse Securities.

Kurt Stumpo - Journalist

Jurisdiction:

United States

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Industry sector:

Pharmaceuticals and life sciences


Firm:

Party: Novartis Capital (Issuer)